Insider Trading activities of Biomarin Pharmaceutical Inc insiders. , Part 2

Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Biomarin Pharmaceutical Inc since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Biomarin Pharmaceutical Inc since year 2005. (See page 1 of this report.) Table 2 shows the detailed insider transactions of Biomarin Pharmaceutical Inc since 2005. The reporting company's ticker symbol is BMRN. The reporting company's CIK number is 1048477.
The total value of stock buying since 2005 is $1,114,124.
The total value of stock sales since 2005 is $424,118,306.
The total value of stock option exercises since 2005 is $120,949,502.



Table 2. Detailed insider stock purchases, sales, and option exercises of Biomarin Pharmaceutical Inc insiders (BMRN) , Part 2
  Trade Date   Insider Name Trade Type     Shares       Price ($)   Value ($)
2017-01-25 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 5,000 17.33 86,649
2017-01-11 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 89.84 359,360
2017-01-11 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 17.33 69,320
2017-01-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 91.31 365,240
2017-01-10 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 17.33 69,320
2017-01-09 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 5,000 90.00 450,000
2017-01-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 89.79 359,160
2017-01-09 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 17.33 69,320
2017-01-06 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 87.19 348,760
2017-01-06 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 17.33 69,320
2016-12-30 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 83.35 333,400
2016-12-30 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 17.33 69,320
2016-12-29 Bienaime Jean Jacques (Chief Executive Officer) Sale 4,000 83.84 335,360
2016-12-29 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 4,000 17.33 69,320
2016-11-25 Fuchs Henry J (President, Worldwide R&D) Sale 15,000 87.40 1,310,985
2016-11-25 Fuchs Henry J (President, Worldwide R&D) Option Ex 15,000 26.49 397,350
2016-11-22 Bienaime Jean Jacques (Chief Executive Officer) Sale 69,743 85.69 5,976,486
2016-11-22 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 69,743 26.49 1,847,492
2016-11-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 69,744 87.56 6,106,505
2016-11-21 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 69,744 26.49 1,847,518
2016-11-18 Davis George Eric (EVP, General Counsel) Sale 5,000 90.42 452,100
2016-11-18 Davis George Eric (EVP, General Counsel) Option Ex 5,000 38.59 192,950
2016-11-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 41,670 90.97 3,790,803
2016-11-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 41,670 17.54 730,891
2016-11-09 Lawlis V Bryan Sale 7,500 95.00 712,500
2016-11-09 Lawlis V Bryan Option Ex 7,500 17.33 129,974
2016-11-09 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 20,000 90.61 1,812,200
2016-11-08 Bienaime Jean Jacques (Chief Executive Officer) Sale 70,000 82.83 5,797,820
2016-11-08 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 70,000 21.51 1,505,700
2016-11-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 70,000 82.52 5,776,470
2016-11-07 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 70,000 21.51 1,505,700
2016-10-28 Bienaime Jean Jacques (Chief Executive Officer) Sale 60,000 81.27 4,876,020
2016-10-28 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 60,000 14.39 863,400
2016-10-27 Bienaime Jean Jacques (Chief Executive Officer) Sale 60,000 81.34 4,880,460
2016-10-27 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 60,000 14.39 863,400
2016-10-17 Bienaime Jean Jacques (Chief Executive Officer) Sale 41,666 84.39 3,516,235
2016-10-17 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 41,666 17.54 730,821
2016-10-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 11,000 86.89 955,812
2016-10-14 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 11,000 17.86 196,460
2016-10-13 Bienaime Jean Jacques (Chief Executive Officer) Sale 53,125 86.97 4,620,546
2016-10-13 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 53,125 38.59 2,050,093
2016-09-30 Bienaime Jean Jacques (Chief Executive Officer) Sale 53,125 92.02 4,888,775
2016-09-30 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 53,125 38.59 2,050,093
2016-09-29 Bienaime Jean Jacques (Chief Executive Officer) Sale 53,125 93.64 4,974,890
2016-09-29 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 53,125 38.59 2,050,093
2016-09-27 Ajer Jeffrey Robert (EVP, Chief Commercial Officer) Sale 18,467 95.61 1,765,648
2016-09-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 94,791 95.61 9,062,683
2016-09-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 94,791 28.07 2,660,309
2016-09-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 42,577 94.85 4,038,343
2016-09-15 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 42,577 17.33 737,859
2016-08-26 Fuchs Henry J (EVP, Chief Medical Officer) Sale 15,000 95.06 1,425,930
2016-08-26 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 15,000 26.49 397,350
2016-08-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 41,666 91.49 3,811,855
2016-08-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 41,666 17.54 730,821
2016-08-01 Mueller Brian (VP, Corporate Controller) Sale 287 100.00 28,700
2016-08-01 Davis George Eric (EVP, General Counsel) Sale 2,167 100.00 216,700
2016-08-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 4,000 99.33 397,320
2016-07-27 Lawlis V Bryan Sale 1,100 95.39 104,926
2016-07-27 Lawlis V Bryan Option Ex 1,100 17.33 19,062
2016-07-22 Lawlis V Bryan Sale 6,400 95.01 608,064
2016-07-22 Lawlis V Bryan Option Ex 6,400 17.33 110,911
2016-07-18 Bienaime Jean Jacques (Chief Executive Officer) Sale 41,666 92.72 3,863,271
2016-07-18 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 41,666 17.54 730,821
2016-07-14 Davis George Eric (EVP, General Counsel) Option Ex 2,656 38.59 102,495
2016-07-07 Davis George Eric (EVP, General Counsel) Sale 2,167 90.00 195,030
2016-06-20 Lawlis V Bryan Sale 1,650 82.77 136,569
2016-06-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 83,332 80.55 6,712,392
2016-06-16 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 83,332 17.54 1,461,642
2016-06-06 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 1,649 89.14 146,991
2016-05-31 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 20,841 89.67 1,868,916
2016-05-31 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 16,896 39.06 659,957
2016-05-26 Fuchs Henry J (EVP, Chief Medical Officer) Sale 15,000 87.69 1,315,350
2016-05-26 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 15,000 26.49 397,350
2016-05-23 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 3,769 87.08 328,185
2016-05-18 Baffi Robert (EVP, Technical Operations) Sale 5,000 87.05 435,250
2016-05-10 Davis George Eric (EVP, General Counsel) Sale 4,658 86.32 402,078
2016-05-09 Davis George Eric (EVP, General Counsel) Sale 10,000 84.55 845,530
2016-05-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 50,000 80.15 4,007,450
2016-05-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 70,000 24.18 1,692,810
2016-05-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 36,500 85.01 3,102,938
2016-05-02 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 36,500 12.99 474,135
2016-04-06 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,500 14.39 21,585
2016-04-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 1,500 14.39 21,585
2016-03-14 Davis George Eric (EVP, General Counsel) Sale 1,996 86.21 172,079
2016-03-04 Ajer Jeffrey Robert (SVP, Chief Commercial Officer) Sale 1,255 88.42 110,970
2016-03-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 4,623 86.12 398,118
2016-03-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 84.26 842,600
2016-02-22 Grey Michael G Sale 7,500 80.00 600,000
2016-02-22 Grey Michael G Option Ex 7,500 38.59 289,425
2015-12-16 Davis George Eric (SVP, General Counsel) Sale 1,362 100.00 136,200
2015-11-16 Lawlis V Bryan Sale 8,550 105.76 904,273
2015-11-16 Lawlis V Bryan Option Ex 7,500 17.33 129,974
2015-11-16 Grey Michael G Sale 7,500 104.27 782,055
2015-11-16 Grey Michael G Option Ex 7,500 38.59 289,425
2015-11-16 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 20,000 104.30 2,085,920
2015-11-16 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 20,000 39.06 781,200
2015-11-02 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 26 117.56 3,056
2015-10-15 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 108.24 108,241
2015-09-14 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 131.43 131,432
2015-09-08 Heron Elaine J Option Ex 15,000 21.51 322,650
2015-08-12 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 134.72 202,083
2015-07-20 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 3,000 150.00 450,000
2015-07-20 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 3,000 63.10 189,300
2015-07-07 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 139.07 208,599
2015-06-05 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 1,649 122.30 201,669
2015-06-05 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,864 122.32 228,000
2015-06-04 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 1,362 122.35 166,646
2015-06-01 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 377 123.76 46,656
2015-06-01 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 3,945 124.16 489,811
2015-05-29 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 1,578 126.15 199,064
2015-05-26 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 1,625 126.55 205,647
2015-05-21 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,500 126.11 189,157
2015-05-18 Davis George Eric (SVP, General Counsel) Sale 2,558 125.26 320,415
2015-05-18 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 36,137 127.39 4,687,045
2015-05-18 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,864 124.78 232,584
2015-05-13 Fuchs Henry J (EVP, Chief Medical Officer) Sale 1,434 121.36 174,037
2015-05-11 Fuchs Henry J (EVP, Chief Medical Officer) Sale 2,869 121.64 348,988
2015-05-06 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Sale 34,019 119.17 4,053,942
2015-05-06 Ajer Jeffrey Robert (SVP, Chief Commercial Of) Option Ex 33,631 30.43 1,023,290
2015-05-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 26,723 114.98 3,072,503
2015-05-01 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 23,218 6.46 149,988
2015-05-01 Fuchs Henry J (EVP, Chief Medical Officer) Sale 414 114.59 47,441
2015-04-01 Bienaime Jean Jacques (Chief Executive Officer) Sale 26,052 120.53 3,140,125
2015-04-01 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 22,546 6.46 145,647
2015-03-20 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 126.40 126,396
2015-03-17 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 124.87 124,866
2015-03-16 Bienaime Jean Jacques (Chief Executive Officer) Sale 1,000 123.48 123,477
2015-03-16 Fuchs Henry J (EVP, Chief Medical Officer) Sale 41,315 123.57 5,105,170
2015-03-16 Fuchs Henry J (EVP, Chief Medical Officer) Option Ex 40,000 21.51 860,400
2015-03-13 Davis George Eric (SVP, General Counsel) Sale 15,000 120.87 1,813,005
2015-03-13 Davis George Eric (SVP, General Counsel) Option Ex 15,000 31.98 479,625
2015-03-10 Bienaime Jean Jacques (Chief Executive Officer) Sale 2,021 114.89 232,200
2015-03-09 Bienaime Jean Jacques (Chief Executive Officer) Sale 19,000 112.13 2,130,508
2015-03-09 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 15,000 12.99 194,850
2015-03-05 Baffi Robert (EVP, Technical Operations) Sale 14,051 116.37 1,635,086
2015-03-05 Baffi Robert (EVP, Technical Operations) Option Ex 14,051 16.12 226,572
2015-03-05 Bienaime Jean Jacques (Chief Executive Officer) Sale 10,000 113.70 1,137,020
2015-03-05 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 10,000 12.99 129,900
2015-03-04 Bienaime Jean Jacques (Chief Executive Officer) Sale 916 107.71 98,660
2015-03-04 Bienaime Jean Jacques (Chief Executive Officer) Option Ex 500 9.86 4,930
2015-03-03 Mueller Brian (VP, Corporate Controller) Sale 7,000 109.46 766,213
2015-03-03 Mueller Brian (VP, Corporate Controller) Option Ex 7,000 28.23 197,610
2015-03-03 Bienaime Jean Jacques (Chief Executive Officer) Sale 5,000 107.42 537,095
2015-03-03 Lapalme Pierre Sale 20,000 106.57 2,131,400
2015-03-03 Lapalme Pierre Option Ex 20,000 14.24 284,800
2015-03-02 Davis George Eric (SVP, General Counsel) Sale 23,000 108.31 2,491,038
2015-03-02 Davis George Eric (SVP, General Counsel) Option Ex 23,000 26.49 609,270
2015-03-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Sale 15,500 107.00 1,658,500
2015-03-02 Spiegelman Daniel K (EVP, Chief Financial Officer) Option Ex 15,500 39.06 605,430
2015-03-02 Bienaime Jean Jacques (Chief Executive Officer) Sale 8,000 108.20 865,616

Insider trading activities including stock purchases, stock sales, and option exercises of BMRN listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Biomarin Pharmaceutical Inc (symbol BMRN, CIK number 1048477) see the Securities and Exchange Commission (SEC) website.